Body mass index as a prognostic factor in endometrioid adenocarcinoma of the endometrium.

Abstract

In patients with endometrioid adenocarcinoma, low BMI is associated with high stage and tumor expression of HER-2/neu. Despite better prognostic factors, overweight women experience poorer survival.